Riskpilot← Back to searchSign inGet full accessDIACOR AS
ASActiveOrg 913079450Tevlingveien 23, 1081 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 197611 employees
Revenue 2024
NOK 79,9M
+22% vs 2023
EBITDA margin
4.2%
+311% vs 2023
Equity ratio
28.8%
Financial strength
Net profit 2024
NOK 2,5M
+317% vs 2023
| Revenue | NOK 79,9M | +22% |
| EBITDA | NOK 3,4M | +311% |
| Net profit | NOK 2,5M | +317% |
| Total assets | NOK 38M | +28% |
| Equity | NOK 10,9M | -5% |
| Employees | 11 | — |
Legal name
DIACOR AS
Org number
913079450
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
30. november 1976
Share capital
NOK 3 123 400
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Tevlingveien 23, 1081 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27 758 | 32 325 | 48 340 | 55 877 | 56 367 | 56 303 | 59 553 | 71 050 | 66 287 | 59 818 | 65 477 | 79 922 |
| Staff expenses | −8 316 | −8 319 | −8 360 | −8 107 | −8 992 | −9 249 | −10 196 | −10 914 | −11 303 | −11 376 | −11 927 | −13 394 |
| EBITDA | −297 | −1 895 | 479 | 2 733 | 2 185 | 3 659 | 3 515 | 8 010 | 7 327 | 2 838 | 825 | 3 389 |
| Depreciation & amort. | −750 | −669 | −637 | −243 | −191 | −141 | −29 | −71 | −102 | −120 | −113 | −303 |
| EBIT | −1 047 | −2 564 | −159 | 2 490 | 1 994 | 3 517 | 3 486 | 7 939 | 7 224 | 2 719 | 712 | 3 086 |
| Net financials | 186 | 56 | −109 | 260 | −162 | −23 | 84 | 155 | −134 | 78 | 44 | 119 |
| Profit before tax | −861 | −2 508 | −267 | 2 750 | 1 832 | 3 495 | 3 570 | 8 094 | 7 090 | 2 796 | 756 | 3 204 |
| Tax | −191 | −677 | 83 | 742 | 480 | 847 | 793 | 1 790 | 1 563 | 615 | 164 | 733 |
| Net profit | −669 | −1 831 | −351 | 2 008 | 1 352 | 2 648 | 2 777 | 6 304 | 5 527 | 2 181 | 592 | 2 471 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 23 383 | 19 713 | 23 840 | 25 496 | 23 682 | 24 741 | 27 853 | 32 807 | 34 913 | 24 564 | 29 570 | 37 975 |
| Equity | 13 347 | 11 518 | 11 167 | 11 175 | 11 527 | 12 175 | 12 953 | 13 656 | 11 184 | 12 365 | 11 457 | 10 928 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 10 035 | 8 195 | 12 673 | 14 321 | 12 155 | 12 565 | 14 901 | 19 150 | 23 730 | 12 199 | 18 113 | 27 047 |
| Total debt | 10 035 | 8 195 | 12 673 | 14 321 | 12 155 | 12 565 | 14 901 | 19 150 | 23 730 | 12 199 | 18 113 | 27 047 |
EBITDA margin
4.2%
This company
15.8%
Market median
-73% vs market
20132024
Equity ratio
28.8%
This company
38.2%
Market median
-25% vs market
20132024
Return on equity
22.6%
This company
18.4%
Market median
+23% vs market
20132024
Net profit margin
3.1%
This company
8.1%
Market median
-62% vs market
20132024
Asset turnover
2.10×
This company
1.12×
Market median
+87% vs market
20132024
Debt / equity
2.47×
This company
0.62×
Market median
-298% vs market
20132024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SL Chief Executive Officer | Chief Executive Officer | 2004 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2015 | — | — | |
| Board of Directors | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Eika Invest As | Company | 24.6% | 24.6% | 2024 |
Kanada V As | Company | 12.0% | 12.0% | 2024 |
Wasp As | Company | 12.0% | 12.0% | 2024 |
Kanada Iii As | Company | 12.0% | 12.0% | 2024 |
| Individual | 12.0% | 12.0% | 2024 | |
Gapge As | Company | 12.0% | 12.0% | 2024 |
Wøien Holding As | Company | 12.0% | 12.0% | 2024 |
| Individual | 3.3% | 3.3% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DIACOR AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sigurd Lundh Limtun | Chief Executive Officer | 0 companies |
| Jack Ragnar Lund | Chairman | 0 companies |
| Hilde Wøien | Board of Directors | 0 companies |